178 related articles for article (PubMed ID: 10431154)
1. CTL granules: evolution of vesicles essential for combating virus infections.
Trapani JA; Sutton VR; Smyth MJ
Immunol Today; 1999 Aug; 20(8):351-6. PubMed ID: 10431154
[TBL] [Abstract][Full Text] [Related]
2. Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction.
Edwards KM; Davis JE; Browne KA; Sutton VR; Trapani JA
Immunol Cell Biol; 1999 Feb; 77(1):76-89. PubMed ID: 10101689
[TBL] [Abstract][Full Text] [Related]
3. Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo.
Trapani JA; Davis J; Sutton VR; Smyth MJ
Curr Opin Immunol; 2000 Jun; 12(3):323-9. PubMed ID: 10781403
[TBL] [Abstract][Full Text] [Related]
4. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules.
Zhang M; Park SM; Wang Y; Shah R; Liu N; Murmann AE; Wang CR; Peter ME; Ashton-Rickardt PG
Immunity; 2006 Apr; 24(4):451-61. PubMed ID: 16618603
[TBL] [Abstract][Full Text] [Related]
5. Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation.
Jenne DE; Tschopp J
Immunol Rev; 1988 Mar; 103():53-71. PubMed ID: 3292396
[TBL] [Abstract][Full Text] [Related]
6. Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.
Andrade F
Immunol Rev; 2010 May; 235(1):128-46. PubMed ID: 20536560
[TBL] [Abstract][Full Text] [Related]
7. Involvement of granule proteins in T-cell-mediated cytolysis.
Krähenbühl O; Tschopp J
Nat Immun Cell Growth Regul; 1990; 9(4):274-82. PubMed ID: 2215515
[TBL] [Abstract][Full Text] [Related]
8. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.
Berke G; Rosen D
J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748
[TBL] [Abstract][Full Text] [Related]
9. Granzyme B: a natural born killer.
Lord SJ; Rajotte RV; Korbutt GS; Bleackley RC
Immunol Rev; 2003 Jun; 193():31-8. PubMed ID: 12752668
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
Berke G; Rosen D; Ronen D
Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocytes: all roads lead to death.
Barry M; Bleackley RC
Nat Rev Immunol; 2002 Jun; 2(6):401-9. PubMed ID: 12093006
[TBL] [Abstract][Full Text] [Related]
12. Perforin and the granule exocytosis cytotoxicity pathway.
Catalfamo M; Henkart PA
Curr Opin Immunol; 2003 Oct; 15(5):522-7. PubMed ID: 14499260
[TBL] [Abstract][Full Text] [Related]
13. CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis.
Tewari M; Telford WG; Miller RA; Dixit VM
J Biol Chem; 1995 Sep; 270(39):22705-8. PubMed ID: 7559394
[TBL] [Abstract][Full Text] [Related]
14. Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes.
Trenn G; Takayama H; Sitkovsky MV
Nature; 1987 Nov 5-11; 330(6143):72-4. PubMed ID: 3118213
[TBL] [Abstract][Full Text] [Related]
15. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
[TBL] [Abstract][Full Text] [Related]
16. Granzymes: exogenous proteinases that induce target cell apoptosis.
Smyth MJ; Trapani JA
Immunol Today; 1995 Apr; 16(4):202-6. PubMed ID: 7734049
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase I is enriched in granules of in vitro- and in vivo-activated cytotoxic T lymphocytes.
Brown GR; McGuire MJ; Thiele DL
J Immunol; 1993 Jun; 150(11):4733-42. PubMed ID: 8496587
[TBL] [Abstract][Full Text] [Related]
18. Granzyme B plays a critical role in cytotoxic lymphocyte-induced apoptosis.
Shresta S; Heusel JW; Macivor DM; Wesselschmidt RL; Russell JH; Ley TJ
Immunol Rev; 1995 Aug; 146():211-21. PubMed ID: 7493755
[No Abstract] [Full Text] [Related]
19. Does the serpin PI-9 protect tumor cells?
Bots M; Offringa R; Medema JP
Blood; 2006 Jun; 107(12):4974-5; author reply 4975. PubMed ID: 16754780
[No Abstract] [Full Text] [Related]
20. Characterization of a granule-independent lytic mechanism used by CTL hybridomas.
Garner R; Helgason CD; Atkinson EA; Pinkoski MJ; Ostergaard HL; Sorensen O; Fu A; Lapchak PH; Rabinovitch A; McElhaney JE
J Immunol; 1994 Dec; 153(12):5413-21. PubMed ID: 7527440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
